Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies
Authors:
- Flavio PaternoFPFlavio Paterno
- Alin GirnitaAGAlin Girnita
- Paul BraileyPBPaul Brailey
- David WitteDWDavid Witte
- Jiang WangJWJiang Wang
- Madison C. CuffyMCMadison C. Cuffy
- Tayyab DiwanTDTayyab Diwan
- Simon TremblaySTSimon Tremblay
- Jane Y. RevolloJRJane Y. Revollo
- Rita R. AllowayRARita R. Alloway
- Michael R. SchoechMSMichael R. Schoech
- Nadim AnwarNANadim Anwar
Open Access
- 1 December 2016
- journal article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 2 (12) , e121
Abstract
The results of simultaneous liver-kidney transplants in highly sensitized recipients have been controversial in terms of antibody-mediated rejection and kidney allograft outcomes. This case report provides a detailed and sophisticated documentation of histocompatibility and pathologic data in a simultaneous liver-kidney transplant performed in a recipient with multiple high-titered class I and II antidonor HLA antibodies and a strongly positive cytotoxic crossmatch. Patient received induction with steroids, rituximab, and eculizumab without lymphocyte depleting agents. The kidney transplant was delayed by 6 hours after the liver transplant to allow more time to the liver allograft to “absorb” donor-specific antibodies (DSA). Interestingly, the liver allograft did not prevent immediate antibody-mediated injury to the kidney allograft in this highly sensitized recipient. Anti-HLA single antigen bead analysis of liver and kidney allograft biopsy eluates revealed deposition of both class I and II DSA in both liver and kidney transplants during the first 2 weeks after transplant. Afterward, both liver and kidney allograft functions improved and remained normal after a year with progressive reduction in serum DSA values.Keywords
This publication has 16 references indexed in Scilit:
- Outcomes of Simultaneous Liver and Kidney Transplantation in Relation to a High Level of Preformed Donor-Specific AntibodiesTransplantation, 2013
- Class II Alloantibody and Mortality in Simultaneous Liver-Kidney TransplantationAmerican Journal of Transplantation, 2013
- Combined Liver-Kidney Transplants: Allosensitization and Recipient OutcomesTransplantation, 2011
- Donor-Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney TransplantsAmerican Journal of Transplantation, 2011
- Outcomes of Simultaneous Liver/Kidney Transplants Are Equivalent to Kidney Transplant Alone: A Preliminary ReportTransplantation, 2010
- Simultaneous liver and kidney transplantationCurrent Opinion in Nephrology and Hypertension, 2007
- Comparison of Renal Allograft Outcomes in Combined Liver-Kidney Transplantation Versus Subsequent Kidney Transplantation in Liver Transplant Recipients: Analysis of UNOS DatabaseTransplantation, 2006
- Long-term Analysis of Combined Liver and Kidney Transplantation at a Single CenterArchives of Surgery, 2006
- Incidence of Renal and Liver Rejection and Patient Survival Rate Following Combined Liver and Kidney TransplantationAmerican Journal of Transplantation, 2003
- Combined liver-kidney transplantation in patients with cirrhosis and renal failure: Effect of a positive cross-match and benefits of combined transplantationLiver Transplantation and Surgery, 1998